Published in Lab Law Weekly, January 12th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Cutting Edge Information.
Report 1: The cost per patient of running Phase III clinical studies of new pharmaceuticals exceeds $26,000, on average, according to a new benchmarking report, "Clinical Operations: Accelerating Trials, Allocating Resources and Measuring Performance," published by business intelligence firm Cutting Edge Information.
The company surveyed dozens of leading pharmaceutical and biotech companies about their clinical development spending, staffing, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.